According to a study published by The Lancet on Monday, the first use of embryonic stem cells in humans eased a degenerative form of blindness in two volunteers and showed no signs of any adverse effects.

The results of the cautious first-stage test that was designed to examine whether the treatment is safe, had been previously announced by Massachusetts biotech firm Advanced Cell Technology (ACT) Inc.

“The Stargardt’s patient reports that she can see more colour and has better contract and dark adaptation out of the operated eye. In fact, she started using her computer and could even read her watch… (and) says she can even thread a needle now,” Bob Lanza, ACT’s chief scientific officer, said in an email to AFP.

Random Posts

• Weight Loss Surgery Trebles Among Teenagers
• Masteron Enanthate – Highly effective Anabolic Steroid
• HIV Drugs Not Associated With Child Psychiatric Problems
• Avent Bottle Warmers
• Healthy diet of Lady Gaga